Cyclooxygenase-2 inhibition prevents renal toxicity but not hypertension during sunitinib treatment

被引:0
|
作者
van Dorst, Daan C. H. [1 ,2 ,6 ]
Colafella, Katrina M. Mirabito [3 ,4 ]
van Veghel, Richard [1 ]
Garrelds, Ingrid M. [1 ]
de Vries, Rene [1 ]
Mathijssen, Ron H. J. [2 ]
Danser, A. H. Jan [1 ]
Versmissen, Jorie [1 ,5 ]
机构
[1] Erasmus MC Univ Med Ctr, Dept Internal Med, Div Vasc Med & Pharmacol, Rotterdam, Netherlands
[2] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands
[3] Monash Univ, Biomed Discovery Inst, Cardiovasc Dis Program, Melbourne, Australia
[4] Monash Univ, Dept Physiol, Melbourne, Australia
[5] Erasmus MC Univ Med Ctr, Dept Hosp Pharm, Rotterdam, Netherlands
[6] Dept Internal Med, Div Pharmacol & Vasc Med, room EE-1424 Erasmus MC Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands
关键词
Cardio-oncology; Angiogenesis inhibitors; Hypertension; Renal toxicity; Cyclooxygenase-2; Prostanoids; BLOOD-PRESSURE; PROSTACYCLIN SYNTHESIS; ARACHIDONIC-ACID; CELECOXIB; COX-2; ACTIVATION; ILOPROST; MODEL;
D O I
10.1016/j.ejphar.2023.176199
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Anticancer angiogenesis inhibitors cause hypertension and renal injury. Previously we observed in rats that high-dose aspirin (capable of blocking cyclooxygenase (COX)-1 and-2) was superior to low-dose aspirin (blocking COX-1 only) to prevent these side-effects during treatment with the angiogenesis inhibitor sunitinib, suggesting a role for COX-2. High-dose aspirin additionally prevented the rise in COX-derived prostacyclin (PGI(2)). Therefore, we studied the preventive effects of selective COX-2 inhibition and the hypothesized contributing role of PGI(2) during angiogenesis inhibition.Methods: Male WKY rats received vehicle, sunitinib ((SU), 14 mg/kg/day) alone or combined with COX-2 inhibition (celecoxib, 10 mg/kg/day) or a PGI(2) analogue (iloprost, 100 mu g/kg/day) for 8 days (n = 8-9 per group). Mean arterial pressure (MAP) was measured via radiotelemetry, biochemical measurements were performed via ELISA and vascular function was assessed via wire myography.Results: SU increased MAP (17 +/- 1mmHg versus 3 +/- 1mmHg after vehicle on day 4, P < 0.002), which could not be significantly blunted by celecoxib (+12 +/- 3mmHg on day 4, P = 0.247), but was temporarily attenuated by iloprost (treatment days 1 + 2 only). Urinary PGI(2) (996 +/- 112 versus 51 +/- 11ng/24h after vehicle, P < 0.001), but not circulating PGI(2) increased during SU, which remained unaffected by celecoxib and iloprost. Celecoxib reduced sunitinib-induced albuminuria (0.36 +/- 0.05 versus 0.58 +/- 0.05mg/24h after SU, P = 0.005). Wire myography demonstrated increased vasoconstriction to endothelin-1 after SU (Emax P = 0.005 versus vehicle), which remained unaffected by celecoxib or iloprost.Conclusion: Selective COX-2 inhibition ameliorates albuminuria during angiogenesis inhibition with sunitinib, which most likely acts independently of PGI(2). To combat angiogenesis inhibitor-induced hypertension, dual rather than selective COX-1/2 blockade seems preferential.
引用
收藏
页数:11
相关论文
共 50 条
  • [11] Effect of cyclooxygenase-2 inhibition on renal function after renal ablation
    Sanchez, PL
    Salgado, LM
    Ferreri, NR
    Escalante, B
    HYPERTENSION, 1999, 34 (04) : 848 - 853
  • [12] Role of cyclooxygenase-2 in regulation of renal function during angiotensin converting enzyme inhibition
    Rodriguez, JA
    Green, T
    Navar, LG
    FASEB JOURNAL, 2005, 19 (05): : A1146 - A1146
  • [13] Renal angiotensin II effects during inhibition of cyclooxygenase-2 and nitric oxide synthesis
    López, R
    Llinás, MT
    Salazar, FJ
    FASEB JOURNAL, 2004, 18 (04): : A737 - A737
  • [14] Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
    Rajnish A. Gupta
    Raymond N. DuBois
    Nature Reviews Cancer, 2001, 1 : 11 - 21
  • [15] Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
    Gupta, RA
    DuBois, RN
    NATURE REVIEWS CANCER, 2001, 1 (01) : 11 - 21
  • [16] Renal Cyclooxygenase-2 Expression And Hemodynamic Role During Angiotensin II-dependent Hypertension
    Gonzalez, Alexis A.
    Green, Torrance
    Bourgeois, Camille R.
    Luffman, Christina
    Prieto, Minolfa C.
    Navar, L. G.
    HYPERTENSION, 2013, 62 (03)
  • [17] Cyclooxygenase-2 inhibition and coagulation
    Steffel, Jan
    Luescher, Thomas F.
    Ruschitzka, Frank
    Tanner, Felix C.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 47 : S15 - S20
  • [18] Cyclooxygenase-2 inhibition prevents colorectal cancer: From the bench to the bed side
    Samoha, S
    Arber, N
    ONCOLOGY, 2005, 69 : 33 - 37
  • [19] Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse
    Gross, G
    Imamura, T
    Vogt, SK
    Wozniak, DF
    Nelson, DM
    Sadovsky, Y
    Muglia, LJ
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2000, 278 (06) : R1415 - R1423
  • [20] Renal hemodynamic responses to cyclooxygenase-2 inhibition in NaCl restricted rats
    Green, TT
    Navar, LG
    FASEB JOURNAL, 2004, 18 (04): : A289 - A290